Sanofi set to buy Bioverativ for more than $11.5 billion: WSJ
Read More
Bagikan Berita Ini
Minggu, 21 Januari 2018
News Business
Sanofi set to buy Bioverativ for more than $11.5 billion: WSJ
(Reuters) - Sanofi SA is close to a deal to take over U.S. drug maker Bioverativ Inc for more than $11.5 billion, the Wall Street Journal reported, citing people familiar with the matter.
Sanofi set to buy Bioverativ for more than $11.5 billion: WSJ
Read More
Bagikan Berita Ini
Sanofi set to buy Bioverativ for more than $11.5 billion: WSJ
Read More
Bagikan Berita Ini
0 Response to "Sanofi set to buy Bioverativ for more than $11.5 billion: WSJ"
Posting Komentar